This article is available online at http://www.jlr.org turnover and decreases HDL cholesterol (HDL-C) and apolipoprotein A-1 (apoA-1) content ( 3-5 ), resulting in an overall decrease in plasma levels of HDL particles. In addition to reducing plasma HDL-C, EL elicits other proatherogenic effects, including increased free fatty acid and lyso-phosphatidycholine , monocyte adhesion to the vessel wall ( 6 ), and increased levels of plasma small dense LDL ( 7 ). EL is expressed in mouse aorta ( 8 ), and its expression is upregulated in response to various infl ammatory mediators such as interleukin-1  (IL-1  ), tumor necrosis factor-␣ (TNF-␣ ) ( 9 ), and IFN-␥ ( 10 ). EL expression is also upregulated in the aortas of apoE Ϫ / Ϫ mice, a model for atherosclerosis research ( 8 ). Thus, the role of EL in lipoprotein metabolism is highly responsive to the proinfl ammatory conditions found in atherosclerotic plaques. Inhibition of EL with an anti-EL antibody increases HDL in several mouse strains, with no increase in triglyceride (TG), LDL, or VLDL ( 11 ). In addition, HDL particles were increased approximately 60% in EL knockout mice ( 12, 13 ). More signifi cantly, the atherosclerotic lesion area in EL/apoE double-knockout mice was reduced by 70% ( 6 ) and was accompanied by increased plasma HDL and reduced vessel macrophage content. However, a more recent study of both EL/apoE and EL/LDLR double-knockout mice did not show signifi cant improvement in the lesion area, despite clear increases in HDL ( 14 ). The reason for this discrepancy is not known but may be the result of differences in environmental factors or stage of development of the atherosclerotic lesions at the time of measurement. Endothelial lipase (EL), a phospholipase A 1 (PLA 1 ) subfamily lipase, has gained attention as a potential therapeutic target for raising HDL and protecting against atherosclerotic plaque formation ( 1, 2 ). EL is a secreted enzyme that subsequently becomes associated with the surface of endothelial cells, where it retains its enzymatic activity ( 1, 2 ). Therefore, EL resides in the proximity of the plasma compartment, where it alters lipoproteins and regulates lipoprotein metabolism. Its primary function is the hydrolysis of HDL phospholipids, which increases HDL
Abstract Endothelial lipase (EL) is